Guardant Health
GH
#1737
Rank
โ‚ฌ10.01 B
Marketcap
76,33ย โ‚ฌ
Share price
1.76%
Change (1 day)
78.87%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -โ‚ฌ0.37 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚ฌ0.98 Billion. , an increase over its 2024 earnings that were of -โ‚ฌ0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚ฌ0.37 Billion-4.03%
2024 -โ‚ฌ0.38 Billion-9.12%
2023 -โ‚ฌ0.42 Billion-26.73%
2022 -โ‚ฌ0.57 Billion69.96%
2021 -โ‚ฌ0.34 Billion56.35%
2020 -โ‚ฌ0.22 Billion252.69%
2019 -โ‚ฌ60.41 Million-17.22%
2018 -โ‚ฌ72.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-โ‚ฌ0.54 Billion 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚ฌ0.24 Billion-35.79%๐Ÿ‡บ๐Ÿ‡ธ USA